Hyperhomocysteinemia and endothelial function in young subjects: effects of vitamin supplementation

Sandra Hirsch1, M Pia De la Maza, Paulina Yañez

  • 1Institute of Nutrition and Food Technology, University of Chile, Santiago. shirsch@uec.inta.uchile.cl

Clinical Cardiology
|November 15, 2002
PubMed

Insights

Mild hyperhomocysteinemia in young men is not linked to endothelial dysfunction. Vitamin supplementation did not improve endothelial function, suggesting total homocysteine (tHcy) levels may be more related to vitamin B12 than folic acid.

Area of Science:

  • Cardiovascular Science
  • Nutritional Biochemistry
  • Vascular Biology

Background:

  • The link between elevated total homocysteine (tHcy) and cardiovascular disease (CVD) requires further clarification.
  • Endothelial dysfunction is an early marker of CVD.

Purpose of the Study:

  • To investigate the association between hyperhomocysteinemia and endothelial dysfunction in young males without other cardiovascular risk factors.
  • To assess the impact of vitamin supplementation on total homocysteine (tHcy) levels and endothelial function.

Main Methods:

  • Recruited 20 hyperhomocysteinemic and 20 normohomocysteinemic young males, excluding those with CVD risk factors.
  • Measured serum tHcy, vitamin B12, folate, coagulation factors, and LDL oxidation.
  • Assessed endothelial-dependent (EDD) and independent dilatation (EID) via ultrasound before and after 8-week vitamin (folic acid, B12, B6) or placebo supplementation.

Main Results:

  • Hyperhomocysteinemic subjects had lower baseline vitamin B12 levels.
  • Vitamin supplementation significantly reduced plasma tHcy and increased serum folic acid and vitamin B12 levels in supplemented groups.
  • No significant improvement in endothelial-dependent dilatation (EDD) or antithrombotic function was observed after vitamin treatment.

Conclusions:

  • Mild hyperhomocysteinemia is not associated with endothelial dysfunction in young males lacking other cardiovascular risk factors.
  • Vitamin-induced reduction of tHcy did not improve endothelial function in this cohort.
  • The study suggests a stronger relationship between tHcy levels and vitamin B12 status compared to folic acid.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...